February 12, 2015 | Evogene, the Israeli crop engineering company, announced that it will open a research and development center in St. Louis, Missouri. The R&D center will go up in the city’s Bio-Research & Development Growth Park, costing the company an estimated $10 million. Evogene hopes that the move and the new facilities will advance the company’s predictive discovery and validation capabilities, as they pertain the company’s insect control technologies. The project is set to be complete by the end of 2015. Evogene was founded in 2002 by Dr. Hagai Karchi and Dr. Rafi Meissner, and went public on NASDAQ in 2013, raises $74 million through its public offering.